Publications by authors named "E Soydan"

Background: The aim of this study is the evaluation of a closed-loop oxygen control system in pediatric patients undergoing invasive mechanical ventilation (IMV).

Methods: Cross-over, multicenter, randomized, single-blind clinical trial. Patients between the ages of 1 month and 18 years who were undergoing IMV therapy for acute hypoxemic respiratory failure (AHRF) were assigned at random to either begin with a 2-hour period of closed-loop oxygen control or manual oxygen titrations.

View Article and Find Full Text PDF

Background: In pediatric intensive care units, extubation failure following invasive mechanical ventilation poses significant health risks. Determining readiness for extubation in children can minimize associated morbidity and mortality. This study investigates the potential role of renal near-infrared spectroscopy (RrSO2) in predicting extubation failure in pediatric patients.

View Article and Find Full Text PDF

Pediatric septic shock is defined as progressive multi-organ dysfunction and cardiovascular dysfunction accompanying sepsis. Studies showing myocardial dysfunction associated with pediatric septic shock are very limited. The aim of this study was to evaluate the relationship between myocardial functions calculated by echocardiography, disease severity, and clinical outcomes in children with septic shock.

View Article and Find Full Text PDF

Commercially important trout species, especially rainbow trout, are under great threat due to several negative factors affecting oxygen levels in water such as global warming and eutrophication. In our study, rainbow trout (Oncorhynchus mykiss) was exposed to chronic (for 28 days) hypoxia (4.0 ± 0.

View Article and Find Full Text PDF
Article Synopsis
  • This study looked at patients in Turkey with a type of cancer called primary mediastinal B-cell lymphoma (PMBL) to see how well different treatments work.
  • They checked 61 patients and found that many responded well to treatments like R-CHOP and DA-EPOCH-R, with a 77% overall response rate.
  • The results also showed that most patients lived for about 25 months after treatment, with good outcomes even 5 years later, making these treatments some of the best options available.
View Article and Find Full Text PDF